Clinical Trial Update: Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating an anti-PD-L1 agent in combination with chemotherapy and/or radiotherapy for esophageal cancer has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Anti-PD-L1 agent

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-03-22